Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

REPX Riley Exploration Permian, Inc.
$27.19 -1.24% -0.34
Notify me if price changes either direction
Interactive Brokers Logotype

Buy REPX stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 598.7M
Enterprise value 954.7M
Trailing PE 6.726601
Forward PE 6.0154185
PEG Ratio -0.18236562711111
Enterprise to EBITDA 3.807
Enterprise to revenue 2.402
Price to book MRQ 1.0610358
Price to sales TTM 1.5147879

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 397.4M
EBITDA 238.2M
Diluted EPS TTM 4.06
Total Cash (MRQ) 16.5M
Current ratio (MRQ) 0.624
Operating Cash Flow (TTM) 214.0M

REPX trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent REPX News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.